|
Volumn 241, Issue 2, 1993, Pages 96-100
|
Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system preliminary data
a a a a a a |
Author keywords
Cerebral non Hodgkin's lymphoma; Chemotherapy; Highdose methotrexate
|
Indexed keywords
BLEOMYCIN;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DOXORUBICIN;
FOLINIC ACID;
METHOTREXATE;
VINCRISTINE;
ADULT;
AGED;
ARTICLE;
BOLUS INJECTION;
BRAIN TUMOR;
CENTRAL NERVOUS SYSTEM;
CHEMOTHERAPY;
CLINICAL ARTICLE;
DRUG EFFICACY;
DRUG MEGADOSE;
HISTOLOGY;
HUMAN;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
RADIOTHERAPY;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
BRAIN NEOPLASMS;
COMBINED MODALITY THERAPY;
CRANIAL IRRADIATION;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DOXORUBICIN;
FEMALE;
FOLLOW-UP STUDIES;
HUMAN;
LEUCOVORIN;
LYMPHOMA, NON-HODGKIN;
MALE;
METHOTREXATE;
MIDDLE AGE;
REMISSION INDUCTION;
TIME FACTORS;
TREATMENT OUTCOME;
VINCRISTINE;
|
EID: 0027382274
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/BF00869771 Document Type: Article |
Times cited : (40)
|
References (36)
|